Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 9/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.43 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.42 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.41 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.41 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.40 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13801123 | 0.82 | CRHBP (0.46) | ALOX15HTR2CKDM4EALDH1A1LMNA | |
| SCHEMBL251035 | 0.81 | KDM4E (0.53) | ALOX15HTR2CKDM4EALDH1A1LMNA | |
| SCHEMBL2225061 | 0.79 | KDM4E (0.64) | ALOX15KDM4EALDH1A1LMNAHSD17B10 | |
| SCHEMBL30689066 | 0.79 | KDM4E (0.64) | ALOX15KDM4EALDH1A1LMNAHSD17B10 | |
| SCHEMBL13801122 | 0.78 | CYP11B1 (0.44) | KDM4EALDH1A1LMNAHPGDHSD17B10 | |
| SCHEMBL12914313 | 0.78 | PTPN11 (0.50) | ALOX15HTR2CKDM4EALDH1A1LMNA | |
| SCHEMBL13801124 | 0.77 | ALDH1A1 (0.38) | ALOX15HTR2CKDM4EALDH1A1LMNA | |
| SCHEMBL13801114 | 0.76 | CYP1A2 (0.50) | ALOX15HTR2CKDM4EALDH1A1LMNA | |
| SCHEMBL13801116 | 0.76 | IDO1 (0.50) | ALOX15KDM4EALDH1A1LMNAHPGD | |
| SCHEMBL25028182 | 0.75 | ALDH1A1 (0.42) | ALOX15KDM4EALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230050869-A1 | THERMOELECTRIC CONVERSION MATERIAL, AND THERMOELECTRIC CONVERSION ELEMENT PREPARED THEREWITH | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2023-02-16 | — | — | US | disclosed |
| EP-3902021-A1 | THERMOELECTRIC CONVERSION MATERIAL, AND THERMOELECTRIC CONVERSION ELEMENT PREPARED THEREWITH | Toyo Ink SC Holdings Co., Ltd. (JP) | 2021-10-27 | — | — | EP | disclosed |
| US-20090156827-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT | TOYO INK MFG. CO., LTD. (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20090156827-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT | TOYO INK MFG. CO., LTD. (JP) | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156827-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT | ELP1, ELAVL1, ELF3 | ALOX15 362/4885HTR2C 4158/4885KDM4E 1648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.